Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...

Diabetic Retinopathy

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...

Diabetic Nephropathy

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...

Proteoglycans

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Concerted action of ANP and dopamine D1-receptor to regulate sodium homeostasis in nephrotic syndrome.

BioMed research international·2013

Same author

Membrane and soluble forms of endoglin in preeclampsia.

Current molecular medicine·2013

Same author

Effects and mechanism of organ protection by cardiotrophin-1.

Current medicinal chemistry·2012

Same author

Effect of nitric oxide synthesis modification on renal function in gentamicin-induced nephrotoxicity.

Environmental toxicology and pharmacology·2011

Same author

Kidney androgen-regulated protein transgenic mice show hypertension and renal alterations mediated by oxidative stress.

Circulation·2009

Same author

Teaching integrative physiology using the quantitative circulatory physiology model and case discussion method: evaluation of the learning experience.

Advances in physiology education·2008

Search research articles

Related Experiment Video

Updated: Jun 2, 2026

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

Published on: January 12, 2024

Osteoprotegerin and diabetes-associated pathologies.

A M Blázquez-Medela¹, J M López-Novoa, C Martínez-Salgado

¹Unidad de Fisiopatología Renal y Cardiovascular, Instituto Reina Sofía de Investigación Nefrológica, Universidad de Salamanca, Spain.

Current Molecular Medicine

|May 17, 2011

Summary

Osteoprotegerin (OPG) is linked to diabetes and its complications. This review explores OPG's role in diabetic vascular disease, including atherosclerosis and nephropathy.

Related Experiment Videos

Last Updated: Jun 2, 2026

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

Published on: January 12, 2024

Area of Science:

Endocrinology and Metabolism
Vascular Biology
Bone Biology

Background:

Osteoprotegerin (OPG) is a cytokine initially known for its anti-resorptive properties.
Emerging evidence suggests OPG plays a role in linking bone and vascular health.
Recent studies highlight a significant association between OPG and diabetes development.

Purpose of the Study:

To review the multifaceted role of Osteoprotegerin (OPG) in diabetic patients.
To analyze the connections between OPG and major diabetes-associated vascular diseases.
To explore OPG's relationship with related conditions like fibrosis, obesity, and metabolic syndrome.

Main Methods:

Literature review of studies investigating Osteoprotegerin (OPG) in diabetes.
Analysis of research on OPG's involvement in atherosclerosis, hypertension, and endothelial dysfunction.
Examination of OPG's role in diabetic nephropathy and other related pathologies.

Main Results:

Osteoprotegerin (OPG) is increasingly recognized as a key factor in the pathogenesis of diabetic complications.
Studies show a strong correlation between elevated OPG levels and the severity of vascular damage in diabetes.
OPG is implicated in conditions such as fibrosis, obesity, and metabolic syndrome, exacerbating diabetic risks.

Conclusions:

Osteoprotegerin (OPG) represents a potential therapeutic target for managing vascular complications in diabetes.
Understanding the complex role of OPG is crucial for developing novel strategies against diabetes-related comorbidities.
Further research into OPG's mechanisms may offer new avenues for treatment in metabolic and vascular diseases.